We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Losses an Ominous Sign For Merck's Vioxx Strategy
Court Losses an Ominous Sign For Merck's Vioxx Strategy
September 1, 2006
Merck’s recent losses in federal and state court signal not only flaws in the company’s legal strategy in fighting thousands of lawsuits involving its pain-relief drug Vioxx, but also more liability than originally anticipated, a financial analyst says.